These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32623395)

  • 61. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
    Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
    Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sominone improves memory impairments and increases axonal density in Alzheimer's disease model mice, 5XFAD.
    Joyashiki E; Matsuya Y; Tohda C
    Int J Neurosci; 2011 Apr; 121(4):181-90. PubMed ID: 21329473
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Disease-Modifying Effects of M
    Lebois EP; Schroeder JP; Esparza TJ; Bridges TM; Lindsley CW; Conn PJ; Brody DL; Daniels JS; Levey AI
    ACS Chem Neurosci; 2017 Jun; 8(6):1177-1187. PubMed ID: 28230352
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disruption of the astrocyte-neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer's disease animal model.
    Choi M; Lee SM; Kim D; Im HI; Kim HS; Jeong YH
    Mol Brain; 2021 Jul; 14(1):111. PubMed ID: 34246283
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation.
    Fine JM; Renner DB; Forsberg AC; Cameron RA; Galick BT; Le C; Conway PM; Stroebel BM; Frey WH; Hanson LR
    Neurosci Lett; 2015 Jan; 584():362-7. PubMed ID: 25445365
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resveratrol improves cognition and decreases amyloid plaque formation in Tg6799 mice.
    Chen Y; Shi GW; Liang ZM; Sheng SY; Shi YS; Peng L; Wang YP; Wang F; Zhang XM
    Mol Med Rep; 2019 May; 19(5):3783-3790. PubMed ID: 30864708
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.
    Cai M; Lee JH; Yang EJ
    J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A
    Kong Y; Peng Q; Lv N; Yuan J; Deng Z; Liang X; Chen S; Wang L
    Neurosci Lett; 2020 Jun; 730():135016. PubMed ID: 32371159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer's disease: Modulation of hippocampal neurogenesis and apoptosis as underlying mechanism.
    Chavoshinezhad S; Mohseni Kouchesfahani H; Ahmadiani A; Dargahi L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109661. PubMed ID: 31152860
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The ethanol extract of Zizyphus jujuba var. spinosa seeds ameliorates the memory deficits in Alzheimer's disease model mice.
    Park HJ; Jung IH; Kwon H; Yu J; Jo E; Kim H; Park SJ; Lee YC; Kim DH; Ryu JH
    J Ethnopharmacol; 2019 Apr; 233():73-79. PubMed ID: 30605739
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.
    de Pins B; Cifuentes-Díaz C; Farah AT; López-Molina L; Montalban E; Sancho-Balsells A; López A; Ginés S; Delgado-García JM; Alberch J; Gruart A; Girault JA; Giralt A
    J Neurosci; 2019 Mar; 39(13):2441-2458. PubMed ID: 30700530
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.
    Cheng YS; Chen ZT; Liao TY; Lin C; Shen HC; Wang YH; Chang CW; Liu RS; Chen RP; Tu PH
    EMBO Mol Med; 2017 May; 9(5):703-715. PubMed ID: 28356312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.